メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
日本大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
専門家に連絡
Scopus著者プロファイル
黒沼 圭一郎
助教
医学部
h-index
648
被引用数
12
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2016
2024
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(44)
類似のプロファイル
(6)
フィンガープリント
Keiichiro Kuronumaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Adipose Tissue
32%
Age
17%
All Cause Mortality
20%
Analysis
22%
Anticoagulant Therapy
20%
Antithrombotic
17%
Apoplexy
42%
Assessment
24%
Atorvastatin
16%
Atrial Fibrillation
100%
Blood Oxygenation
16%
Body Mass Index
20%
Cardiac PET
16%
Cardiovascular System
23%
Cholesterol
16%
Combination Therapy
26%
Computed Tomography Angiography
39%
Coronary Artery
47%
Coronary Artery Disease
69%
Direct Oral Anticoagulant
32%
Embolism
23%
Fibrosis
16%
Fractional Flow Reserve
34%
Heart Muscle Perfusion
16%
Inpatient
84%
Ischemia
25%
Isotope
16%
Isotopes of Calcium
32%
Learning
32%
Major Adverse Cardiac Event
24%
Major Bleeding
28%
Microcirculation
20%
Monitoring
16%
Mortality
20%
Myocardial Perfusion Imaging
39%
near Infrared Spectroscopy
48%
Patient
93%
Patient Satisfaction
16%
Physician
16%
Plaque
48%
Rest
16%
Resuscitation
16%
Risk Stratification
34%
Sex Difference
16%
Short Term Memory
16%
Single-Photon Emission Computed Tomography
32%
Statin
24%
Stenosis
18%
Transformer
16%
Vascular Occlusion
25%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Coronary Syndrome
16%
All Cause Mortality
16%
Antibiotic Agent
5%
Anticoagulant Agent
19%
Atorvastatin
16%
Atrial Fibrillation
85%
Bevacizumab
5%
Biological Marker
5%
Bleeding
14%
Blood Vessel Occlusion
19%
Cardiovascular Risk
5%
Cause of Death
7%
Coronary Artery Disease
16%
Death
24%
Direct Oral Anticoagulant
24%
Dyspnea
5%
Embolism
19%
Gastrointestinal Hemorrhage
16%
Heart Failure
5%
Human Serum Albumin
5%
Incidence
12%
Inflammation
16%
Infrared Spectroscopy
32%
Lung Adenocarcinoma
16%
Major Adverse Cardiac Event
16%
Mortality
7%
Mortality Rate
5%
Oxyhemoglobin
6%
Pericarditis
16%
Platinum
5%
Pleurisy
16%
Regadenoson
10%
Rubidium 82
5%
Rubidium 82
5%
Side Effect
5%
Staphylococcal Bacteremia
5%
Statin (Protein)
32%
Thrombus
16%
Toxic Injury
12%
Vanilla
12%
Warfarin
17%
Nursing and Health Professions
Acute Coronary Syndrome
16%
All Cause Mortality
8%
Anticoagulant Agent
16%
Antivitamin K
5%
Atorvastatin
16%
Atrial Fibrillation
16%
Blood Flowmetry
16%
Blood Vessel Occlusion
11%
Computer Assisted Tomography
16%
Coronary Artery Blood Flow
8%
Diagnosis
16%
Drug Therapy
5%
Embolism
12%
Gamma Camera
16%
Heart Muscle Blood Flow
16%
Heart Muscle Perfusion
10%
Myocardial Perfusion Imaging
32%
near Infrared Spectroscopy
16%
Patient Compliance
5%
Patient Satisfaction
16%
Perfusion
10%
Persistent Atrial Fibrillation
8%
Polyethylene Terephthalate
32%
Positron Emission Tomography
13%
Predictive Value
7%
Radiation Dose
6%
Rubidium 82
16%
Single-Photon Emission Computed Tomography
8%
Standard
16%
Statins therapy
13%
Thallium 201
16%
Thrombus
16%
Tissue Oxygenation
11%
Transesophageal Echocardiography
12%
Warfarin
16%
